# Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB

> **NCT02496013** · PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Arteriovenous Malformation
- Hemangioma
- Neoplasms Lymph Nodes
- Lymphedema

## Interventions

- **DRUG:** 68Ga-NEB

## Key facts

- **NCT ID:** NCT02496013
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2017-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02496013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02496013, "Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02496013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*